Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
- 1 February 1999
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 55 (2), 648-658
- https://doi.org/10.1046/j.1523-1755.1999.00273.x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinImmunology Today, 1994
- Fibrinogen: Its Emerging Role as a Cardiovascular Risk FactorAngiology, 1994
- How HDL protects against atheromaThe Lancet, 1993
- Elevated circulating levels of interleukin-6 in patients with chronic renal failureKidney International, 1991
- Lipid and Apolipoprotein Profiles of Uremic Dyslipoproteinemia -Relation to Renal Function and DialysisNephron, 1991
- Acute-Phase Proteins during Hemodialysis: Correlations with Serum Interleukin-1β Levels and Different Dialysis MembranesNephron, 1991
- Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor αKidney International, 1990
- Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemiasAtherosclerosis, 1983